Keio University Hospital

Keio University Hospital stands as one of Japan's most prestigious academic medical institutions, founded in 1920 in Tokyo's Shinjuku district. Located at 35 Shinanomachi, this tertiary referral hospital serves as the primary clinical facility for Keio University School of Medicine, combining advanced patient care with cutting-edge medical research and education. The hospital embodies the spirit of Fukuzawa Yukichi, founder of Keio University, committing to patient-friendly and trustworthy healthcare delivery. The hospital's comprehensive infrastructure includes 950 beds, making it one of Japan's largest university hospitals. With 36 clinical departments and divisions organized across internal medicine, surgery, neuropsychiatry, pediatrics, and sensory/motor functions, the facility manages substantial patient volumes annually. The medical team comprises over 1,000 healthcare professionals including more than 800 physicians, supported by state-of-the-art diagnostic equipment including advanced CT scanners, 3 Tesla MRI systems, and robotic surgical platforms. Key specializations include cardiology with country-leading catheterization capabilities for cardiovascular diseases, gastroenterology and hepatology providing comprehensive care for digestive disorders, hematology with CAR T-cell therapy authorization and hematopoietic stem cell transplantation, organ transplantation including liver and kidney procedures, and neurosurgery. The hospital pioneered minimally invasive cardiovascular surgery, having performed over 700 small incision heart surgeries—the highest number in Japan. The Skull Base Center conducts the world's first clinical trial using vaccine therapy for difficult-to-treat disorders. Research excellence is integrated through the hospital's designation as one of Japan's fifteen Core Clinical Research Hospitals, receiving substantial government grants for medical innovation. The facility operates as a Special Functioning Hospital since 1994, providing advanced healthcare while conducting medical research, development, evaluation, and training. The hospital's Division of International Patient Services facilitates global access, offering multilingual support and coordination for overseas patients. Accreditation credentials include designation as a Special Functioning Hospital by Japan's Ministry of Health, Labour and Welfare, recognizing its advanced medical capabilities. The hospital holds certification for hematopoietic stem cell transplantation and collection by the Japan Marrow Donor Program, and serves as a designated disaster control base hospital for Tokyo Metropolis. International patients benefit from dedicated coordinator services, medical document translation, and assistance with appointment scheduling. The hospital's central Tokyo location in Shinjuku provides convenient access via public transportation, with Shinanomachi Station serving the facility directly.